GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alpha Cognition Inc (XCNQ:ACOG) » Definitions » Cash Ratio

Alpha Cognition (XCNQ:ACOG) Cash Ratio : 0.53 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Alpha Cognition Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Alpha Cognition's Cash Ratio for the quarter that ended in Dec. 2023 was 0.53.

Alpha Cognition has a Cash Ratio of 0.53. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for Alpha Cognition's Cash Ratio or its related term are showing as below:

XCNQ:ACOG' s Cash Ratio Range Over the Past 10 Years
Min: 0.51   Med: 1.1   Max: 6.27
Current: 0.53

During the past 4 years, Alpha Cognition's highest Cash Ratio was 6.27. The lowest was 0.51. And the median was 1.10.

XCNQ:ACOG's Cash Ratio is ranked worse than
82.13% of 1522 companies
in the Biotechnology industry
Industry Median: 2.85 vs XCNQ:ACOG: 0.53

Alpha Cognition Cash Ratio Historical Data

The historical data trend for Alpha Cognition's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpha Cognition Cash Ratio Chart

Alpha Cognition Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Cash Ratio
1.66 6.27 0.51 0.53

Alpha Cognition Quarterly Data
Jan20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 1.96 1.20 0.24 0.53

Competitive Comparison of Alpha Cognition's Cash Ratio

For the Biotechnology subindustry, Alpha Cognition's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpha Cognition's Cash Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alpha Cognition's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Alpha Cognition's Cash Ratio falls into.



Alpha Cognition Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Alpha Cognition's Cash Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash Ratio (A: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=1.884/3.522
=0.53

Alpha Cognition's Cash Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash Ratio (Q: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=1.884/3.522
=0.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alpha Cognition  (XCNQ:ACOG) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Alpha Cognition Cash Ratio Related Terms

Thank you for viewing the detailed overview of Alpha Cognition's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Alpha Cognition (XCNQ:ACOG) Business Description

Traded in Other Exchanges
Address
301 - 1228 Hamilton Street, Vancouver, BC, CAN, V6B 6L2
Alpha Cognition Inc is a clinical stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, and Cognitive Impairment with Mild Traumatic Brain Injury (mTBI) for which there are limited or no treatment options. The Company is focused on the development of ALPHA-1062 for the treatment of mild-to-moderate Alzheimer's disease and completed an NDA filing to the FDA in September 2023. The company anticipates an FDA approval in mid-2024. The Company's ALPHA-1062 development program is primarily focused on clinical and regulatory development, Chemistry, Manufacturing and Control (CMC) development, and commercial readiness.

Alpha Cognition (XCNQ:ACOG) Headlines

No Headlines